2019
DOI: 10.1101/689984
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Depression, GABA and age correlate with the plasma levels of inflammatory markers

Abstract: Immunomodulation is increasingly being recognised as a part of mental diseases. Here, we examined if levels of immunological protein markers altered with depression, age or by the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).Analysis of plasma samples from patients with major depressive episode and control blood donors (CBD) revealed expression of 67 inflammatory markers. Thirteen of these markers had augmented levels in patients as compared to CBD. and 21 markers correlated with age of the patie… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 74 publications
0
2
0
Order By: Relevance
“…It is indicated that thyroid hormones influence multiple aspects of the GABA system, including the synthesis and degradation of GABA, the expression and function of GABA-A receptor, as well as GABA release and reuptake (Karakatsoulis et al, 2021). Moreover, studies have demonstrated that the GABA system could participate in the pathogenesis of major depressive disorder by possible interactions with different processes involved in this disorder, including monoamine neurotransmission, hypothalamuspituitary-adrenal axis, immune response, and neurotrophic factors (Bhandage et al, 2019;Della Vecchia et al, 2022;Slattery et al, 2005;Suzdak & Gianutsos, 1985). Thyroid abnormalities have been suggested to be associated with the occurrence of stroke and adverse functional outcomes (Squizzato et al, 2005;Wollenweber et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…It is indicated that thyroid hormones influence multiple aspects of the GABA system, including the synthesis and degradation of GABA, the expression and function of GABA-A receptor, as well as GABA release and reuptake (Karakatsoulis et al, 2021). Moreover, studies have demonstrated that the GABA system could participate in the pathogenesis of major depressive disorder by possible interactions with different processes involved in this disorder, including monoamine neurotransmission, hypothalamuspituitary-adrenal axis, immune response, and neurotrophic factors (Bhandage et al, 2019;Della Vecchia et al, 2022;Slattery et al, 2005;Suzdak & Gianutsos, 1985). Thyroid abnormalities have been suggested to be associated with the occurrence of stroke and adverse functional outcomes (Squizzato et al, 2005;Wollenweber et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…autism spectrum disorder (Marotta et al ., 2020). Evidence for altered GABA function comes through multiple lines of enquiry including animal models (Enna and McCarson, 2006; Sun et al ., 2018), genetics (Baulac et al ., 2001; Coghlan et al ., 2012), post-mortem studies (de Jonge et al ., 2017), blood plasma (Petty, 1994; Bhandage et al ., 2019) and in-vivo Magnetic Resonance Spectroscopy (MRS) (Schur et al ., 2016; Peek et al ., 2020). Given the wealth of evidence, targeting the GABAergic system with therapeutic interventions may therefore prove fundamental to improving patient outcomes in these conditions.…”
Section: Introductionmentioning
confidence: 99%